Citation

Jovanovic T, Kazama A, Bachevalier J, Davis M. Neuropharmacology 2012; 62(2): 695-704.

Affiliation

EmoryUniversity School of Medicine, Dept of Psychiatry and Behavioral Sciences, Atlanta, GA.

Copyright

(Copyright © 2012, Elsevier Publishing)

DOI

10.1016/j.neuropharm.2011.02.023

PMID

21377482

PMCID

PMC3146576

Abstract

A dysregulated fear response is one of the hallmark clinical presentations of patients suffering from posttraumatic stress disorder (PTSD). These patients show overgeneralization of fear and in tandem an inability to inhibit fear responses in the presence of safety. Here, we summarize our recent findings using a conditional discrimination paradigm, which assesses safety signal processing (AX+/BX-) in combat and civilian PTSD populations. Overall, PTSD subjects demonstrate a lack of safety signal learning and an inability to modulate the fear responses with safety cues. We then review studies of the neurobiology of fear expression and inhibition in humans and non-humans, in order to provide a background for preliminary studies using reverse translation procedures in which the same AX+/BX- paradigm was used in rhesus macaques.

Language: en